v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue (note 11) $ 5,289 $ 2,832 $ 10,121 $ 6,504
Cost of sales 1,358 1,044 2,719 2,429
Gross profit 3,931 1,788 7,402 4,075
Operating expenses        
Research and development 5,418 4,166 16,324 12,316
Selling, general and administrative 7,426 6,620 24,963 16,476
Total operating expenses 12,844 10,786 41,287 28,792
Operating loss 8,913 8,998 33,885 24,717
Other (income) expenses        
Net finance (income) expense (122) (220) (910) (1,104)
Net foreign exchange (gain) loss (935) 410 1,194 (980)
Total other (income) expenses (1,057) 190 284 (2,084)
Net loss before income taxes 7,856 9,188 34,169 22,633
Income tax expense 100 177 219 236
Deferred tax expense 21   7  
Total income tax expense 121 177 226 236
Net loss attributed to shareholders for the period 7,977 9,365 34,395 22,869
Item that may be reclassified to (income) loss        
Foreign currency translation adjustment 808 (584) (2,008) 855
Net loss and other comprehensive loss for the period $ 8,785 $ 8,781 $ 32,387 $ 23,724
Loss per share (note 12)        
Basic net loss per common share (in dollars per share) $ 0.26 $ 0.38 $ 1.14 $ 0.94
Diluted net loss per common share (in dollars per share) $ 0.26 $ 0.38 $ 1.14 $ 0.94
Basic weighted average common shares outstanding (in shares) 30,104,497 24,534,964 30,119,569 24,427,960
Diluted weighted average common shares outstanding (in shares) 30,104,497 24,534,964 30,119,569 24,427,960
Recurring - non-capital        
Revenue (note 11) $ 4,066 $ 2,653 $ 7,428 $ 5,552
Capital equipment        
Revenue (note 11) $ 1,223 $ 179 $ 2,693 $ 952

Source